Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Immunic, Inc.
Immunic to Participate in Investor and Medical Conferences in May
May 27, 2026
Immunic Appoints Accomplished Biopharmaceutical Executive Michael A. Panzara, M.D., M.P.H., as Chief Medical Officer
May 27, 2026
Immunic, Inc. Announces 1-for-10 Reverse Stock Split
May 26, 2026
Immunic to Participate in Scientific and Medical Conferences in April
May 24, 2026
Immunic Regains Compliance with Nasdaq Minimum Bid Price Requirement
May 23, 2026
Immunic Strengthens Its Board of Directors with the Appointment of Seasoned Biopharmaceutical Executive Jon Congleton
May 22, 2026
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
May 17, 2026
Immunic to Participate in Investor Conferences in March
May 16, 2026
Immunic Highlights 2025 Accomplishments and Upcoming Milestones
January 7, 2026